Liquid Chromatography-Tandem Mass Spectrometry Methods for Determination of Delamanid in Mouse Plasma and Lung
Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53301#.VLydj8nQrzE
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53301#.VLydj8nQrzE
ABSTRACT
Sensitive
and selective liquid chromatography-tandem mass spectrometry methods
have been developed and validated for the determination of delamanid in
mouse plasma and lung. Sample preparation involved liquid-liquid
extraction with diethyl ether for plasma, or protein precipitation
followed by liquid-liquid extraction with tert-butyl methyl ether
for lung homogenate. Chromatographic separation was performed on a
reversed phase column with a linear gradient elution using purified
water-formic acid (1000:2, v/v) and methanol-formic acid (1000:2, v/v)
at a flow rate of 0.2 mL/min. Detection was performed on a
triple-quadrupole tandem mass spectrometer using positive ion
electrospray ionization in the selected reaction monitoring mode. The
analytical methods were successfully validated for selectivity,
calibration curve, accuracy, precision, extraction recovery, and
stability over a range of 6 - 1000 ng/mL for plasma and 10 - 1000 ng/mL
for lung homogenate. The validated methods were successfully applied for
evaluation of pharmacokinetics of delamanid in male mice.
Cite this paper
References
Hirao,
Y. , Koga, T. , Koyama, N. , Shimokawa, Y. and Umehara, K. (2015)
Liquid Chromatography-Tandem Mass Spectrometry Methods for Determination
of Delamanid in Mouse Plasma and Lung. American Journal of Analytical Chemistry, 6, 98-105. doi: 10.4236/ajac.2015.62009.
[1] | Diacon,
A.H., Dawson, R., Hanekom, M., Narunsky, K., Venter, A., Hittel, N.,
Geiter, L.J., Wells, C.D., Paccaly, A.J. and Donald, P.R. (2011) Early
Bactericidal Activity of Delamanid (OPC-67683) in Smear-Positive
Pulmonary Tuberculosis Patients. International Journal of Tuberculosis
& Lung Disease, 15, 949-954. http://dx.doi.org/10.5588/ijtld.10.0616 |
[2] | Gler,
M.T., Skripconoka, V., Sanchez-Garavito, E., Xiao, H., Cabrera-Rivero,
J.L., Vargas-Vasquez, D.E., Gao, M., Awad, M., Park, S.K., Shim, T.S.,
Suh, G.Y., Danilovits, M., Ogata, H., Kurve, A., Chang, J., Suzuki, K.,
Tupasi, T., Koh, W.J., Seaworth, B., Geiter, L.J. and Wells, C.D. (2012)
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis. The New
England Journal of Medicine, 366, 2151-2160. http://dx.doi.org/10.1056/NEJMoa1112433 |
[3] | Skripconoka,
V., Danilovits, M., Pehme, L., Tomson, T., Skenders, G., Kummik, T.,
Cirule, A., Leimane, V., Kurve, A., Levina, K., Geiter, L.J., Manissero,
D. and Wells, C.D. (2013) Delamanid Improves Outcomes and Reduces
Mortality in Multidrug-Resistant Tuberculosis. European Respiratory
Journal, 41, 1393-1400. http://dx.doi.org/10.1183/09031936.00125812 |
[4] | Matsumoto,
M., Hashizume, H., Tomishige, T., Kawasaki, M., Tsubouchi, H., Sasaki,
H., Shimokawa, Y. and Komatsu, M. (2006) OPC-67683, a
Nitro-Dihydro-Imidazooxazole Derivative with Promising Action against
Tuberculosis in Vitro and in Mice. PLOS Medicine, 3, 2131-2144. http://dx.doi.org/10.1371/journal.pmed.0030466 eww150119lx |
评论
发表评论